News
AHEAD Joins NIST Flow Cytometry Standards Consortium for Cell and Gene Therapy
Press (English)2025-03-26
AHEAD CEO Joins ISAC Leadership Development Program as International Innovator
Press (English)2024-12-05
AHEAD Medicine Corporation Reveals Cross-Test AML Diagnostic Technique at ASH 2023
Press (English)2024-01-11
AHEAD Medicine is listed as one of the companies to watch in 2022.
Press (English)2022-01-13